title: Hypoxia acts through multiple signaling pathways to induce metallothionein transactivation by the metal-responsive transcription factor-1 (MTF-1).
abstract: Metal-responsive transcription factor-1 (MTF-1) is essential for the induction of genes encoding metallothionein by metals and hypoxia. Here, we studied the mechanism controlling the activation of MTF-1 by hypoxia. Hypoxia activation of Mt gene transcription is dependent on the presence of metal regulatory elements (MREs) in the promoter of Mt genes. We showed that MREa and MREd are the main elements controlling mouse Mt-1 gene induction by hypoxia. Transfection experiments in Mtf-1-null cells showed that MTF-1 is essential for induction by hypoxia. Chromatin immunoprecipitation analysis showed that MTF-1 DNA-binding activity was strongly enhanced in the presence of zinc but not by hypoxia. Notably, hypoxia inducible factor- (HIF) 1α was recruited to the Mt-1 promoter in response to hypoxia but not to zinc. MTF-1 activation was inhibited by PKC, JNK, and PI3K inhibitors and by the electron transport chain inhibitors rotenone and myxothiazol, but not by the antioxidant N-acetylcysteine. We showed that prolyl-hydroxylase inhibitors can activate MTF-1, but this activation requires the presence of HIF-1α. Finally, HIF-dependent transcription is enhanced in the presence of MTF-1 and induction of an MRE promoter is stimulated by HIF-1α, thus indicating cooperation between these 2 factors. However, coimmunoprecipitation experiments did not suggest direct interaction between MTF-1 and HIF-1α.
authors.affiliation: Centre de recherche en cancérologie de l'Université Laval, CHUQ, Hôtel-Dieu de QC, 9, rue McMahon, QC G1R 2J6, Canada.
authors.forename: Annie
authors.initials: A
authors.lastname: Dubé
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Harrisson
authors.forename: Geneviève
authors.initials: G
authors.lastname: Saint-Gelais
authors.forename: Carl
authors.initials: C
authors.lastname: Séguin
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D015152:Blotting, Northern; D015687:Cell Hypoxia; D002712:Chlorides / Q000494:pharmacology; D002874:Chromosome Mapping; D004268:DNA-Binding Proteins / Q000378:metabolism*; D024202:Electrophoretic Mobility Shift Assay; D017930:Genes, Reporter; D057809:HEK293 Cells; D056945:Hep G2 Cells; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism; D047468:Immunoprecipitation; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D008668:Metallothionein / Q000235:genetics / Q000378:metabolism*; D008689:Methacrylates / Q000494:pharmacology; D051379:Mice; D016297:Mutagenesis, Site-Directed; D041681:NIH 3T3 Cells; D018384:Oxidative Stress; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010957:Plasmids / Q000235:genetics / Q000378:metabolism; D011401:Promoter Regions, Genetic; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D055550:Protein Stability; D012402:Rotenone / Q000494:pharmacology; D015398:Signal Transduction; D013844:Thiazoles / Q000494:pharmacology; D014157:Transcription Factors / Q000378:metabolism*; D015533:Transcriptional Activation; D014162:Transfection; D017967:Zinc Compounds / Q000494:pharmacology; D000097809:Transcription Factor MTF-1
chemical_list: D000111:Acetylcysteine; D002712:Chlorides; D004268:DNA-Binding Proteins; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D008156:Luciferases; D008668:Metallothionein; D008689:Methacrylates; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D012402:Rotenone; D013844:Thiazoles; D014157:Transcription Factors; D017967:Zinc Compounds; D000097809:Transcription Factor MTF-1; C491053:MT2A protein, human; C525355:metallothionein-1, mouse; C030517:myxothiazol; C016837:zinc chloride
references.citation: Cancer Res. 2000 Aug 1;60(15):4010-5
references.pmid: 10945599
references.citation: Mol Cell Biol. 2003 Dec;23(23):8471-85
references.pmid: 14612393
references.citation: Biometals. 2001 Sep-Dec;14(3-4):223-37
references.pmid: 11831458
references.citation: Cancer Res. 2001 Mar 15;61(6):2696-703
references.pmid: 11289150
references.citation: Nucleic Acids Res. 1991 Aug 11;19(15):4225-31
references.pmid: 1870976
references.citation: Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H450-7
references.pmid: 16155105
references.citation: Biochim Biophys Acta. 2004 Mar 4;1654(1):79-94
references.pmid: 14984769
references.citation: J Biol Chem. 2003 May 30;278(22):20235-9
references.pmid: 12649278
references.citation: Cancer Res. 1999 Mar 15;59(6):1315-22
references.pmid: 10096565
references.citation: J Biol Chem. 2002 Jul 19;277(29):26351-5
references.pmid: 12042299
references.citation: J Biol Chem. 2010 Oct 8;285(41):31277-84
references.pmid: 20675386
references.citation: Antioxid Redox Signal. 2001 Aug;3(4):577-96
references.pmid: 11554446
references.citation: J Biol Chem. 1998 Mar 20;273(12):7127-33
references.pmid: 9507026
references.citation: Eur J Biochem. 2000 Mar;267(6):1743-53
references.pmid: 10712606
references.citation: Mol Cancer Res. 2008 Mar;6(3):483-90
references.pmid: 18337454
references.citation: Pflugers Arch. 2005 Sep;450(6):363-71
references.pmid: 16007431
references.citation: J Biol Chem. 1986 Jun 15;261(17):7819-23
references.pmid: 3011801
references.citation: EMBO J. 1993 Apr;12(4):1355-62
references.pmid: 8467794
references.citation: FASEB J. 2004 Aug;18(11):1176-84
references.pmid: 15284217
references.citation: J Biol Chem. 2008 Mar 28;283(13):8190-201
references.pmid: 18230604
references.citation: Mol Cell Biol. 1989 Mar;9(3):1376-80
references.pmid: 2725504
references.citation: J Biol Chem. 2001 Jul 6;276(27):25487-95
references.pmid: 11306562
references.citation: Nucleic Acids Res. 2005 Oct 12;33(18):5715-27
references.pmid: 16221973
references.citation: Biol Chem. 2006 Oct-Nov;387(10-11):1337-46
references.pmid: 17081104
references.citation: J Biol Chem. 1996 Oct 18;271(42):26233-41
references.pmid: 8824273
references.citation: EMBO J. 2003 Aug 15;22(16):4082-90
references.pmid: 12912907
references.citation: Biochem Biophys Res Commun. 2005 Nov 25;337(3):860-7
references.pmid: 16216223
references.citation: Blood. 2005 Oct 1;106(7):2311-7
references.pmid: 15947089
references.citation: J Biol Chem. 2001 Nov 9;276(45):41879-88
references.pmid: 11551972
references.citation: Nucleic Acids Res. 2003 Dec 1;31(23):6710-21
references.pmid: 14627804
references.citation: Biochem Soc Trans. 2008 Dec;36(Pt 6):1252-7
references.pmid: 19021535
references.citation: Nucleic Acids Res. 1995 Jun 25;23(12):2277-86
references.pmid: 7610056
references.citation: DNA Cell Biol. 1998 Jun;17(6):501-10
references.pmid: 9655243
references.citation: Nature. 1985 Oct 31-Nov 6;317(6040):828-31
references.pmid: 4058587
references.citation: Biochem J. 2001 Feb 1;353(Pt 3):591-601
references.pmid: 11171056
references.citation: Biochem Biophys Res Commun. 2008 Mar 28;368(1):88-93
references.pmid: 18206644
references.citation: Science. 2003 Dec 12;302(5652):1975-8
references.pmid: 14671307
references.citation: Nature. 2005 Dec 15;438(7070):932-6
references.pmid: 16355210
references.citation: Bioessays. 2001 Nov;23(11):1010-7
references.pmid: 11746217
references.citation: Biochem Pharmacol. 2000 Jan 1;59(1):95-104
references.pmid: 10605938
references.citation: Genes Dev. 2006 Jun 1;20(11):1458-69
references.pmid: 16751183
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18154-9
references.pmid: 17114296
references.citation: Biol Chem. 2005 Sep;386(9):865-72
references.pmid: 16164411
references.citation: Mutat Res. 2003 Dec 10;533(1-2):201-9
references.pmid: 14643421
references.citation: Biochem J. 2004 Jun 15;380(Pt 3):695-703
references.pmid: 14998373
references.citation: Bull Cancer. 2006 Aug;93(8):E73-80
references.pmid: 16935775
references.citation: Cell Signal. 2005 Jan;17(1):1-9
references.pmid: 15451019
references.citation: EMBO J. 1994 Jun 15;13(12):2870-5
references.pmid: 8026472